0OT

Ocular Therapeutix Inc

Healthcare · EUR · F

0OT

Price

€7.084

+3.28%

Cap

€2.11B

Earnings

30d Trend

-10.6%

0OT
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

85% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality37
Momentum46
Technical45
Fundamentals15

Raw weighted: 38×Macro 0.99 (1%)=38

RISK

85/100
90d Volatility
85.4%High
ATR %
5.0%High daily moves
Max Drawdown (1Y)
-57.3%Volatile

QUALITY

37/100
ROE (avg)
-40.6%Negative
Piotroski F-Score
3/9Weak
Accruals
-7.6%Cash earnings

MOMENTUM

46/100
12-1M Momentum
+13.1%Strong uptrend
6-1M Momentum
-24.0%Negative
1M Return
-0.7%Stable

TECHNICAL

45/100
RSI (14)
54.1Neutral
Price vs SMA200
-15.1%Bearish trend
MACD
-0.05Bearish momentum
Bollinger Band
55%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.014Noisy/choppy

FUNDAMENTALS

15/100
P/S
40.8Expensive

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months35
1-5+ years30

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Ocular Therapeutix Inc at 38/100 — a WEAK reading on the Brain47 Signal. The strongest factor is momentum at 46/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-0.7%

3 MONTHS

+2.3%

12 MONTHS

+12.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (46) and Technical (45) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 85%. I classify this as a speculative position — elevated volatility at 85% and asymmetric payoff potential define the opportunity.

speculativeScore: 38/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.